The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members
Datos Bibliográficos
| ID | 9103729 |
|---|---|
| Autores | Richard E Johnson (0009-0005-9101-9114, Kaiser Permanente Center for Health Research, autor de correspondencia), Michael J Goodman (Kaiser Permanente Center for Health Research), Mark C Hornbrook (0000-0001-6087-0698, Kaiser Permanente Center for Health Research), Michael B Eldredge (Kaiser Permanente Center for Health Research) |
| Año | 1997 |
| Volumen | 35 |
| Número | 11 |
| Páginas | 1119-1131 |
| Fecha de publicación | 1997-11-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00005650-199711000-00004 |
| PMID | 9366891 |
| OpenAlex | W2021281286 |
| Idioma | EN |
| Citas recibidas | 13 |
| Referencias citadas | 13 |
OBJECTIVES: The nature and extent of prescription drug benefits for the elderly are a continuing concern for health-care managers and policy makers. This study examined the impact of increased prescription drug cost-sharing on the drug and medical care utilization and expenses of the elderly. METHODS: Two groups of well-insured Medicare risk-based members of a large health maintenance organization (HMO) had their copayments increased in different years during a 3-year period. Four 2-year analysis periods were established for comparing these elderly groups. During one analysis period, copayments did not change in either group. RESULTS: Moderate increases of from $1 to $3, from $3 to $5 per copayment, and from 50% per dispensing to 70% per dispensing with a maximum payment per dispensing resulted in lower annual per capita prescription drug use and expenses. No consistent annual changes were observed in either medical care utilization (office visits, emergency room visits, home health-care visits, hospitalizations) or total medical care expenses across analysis periods. CONCLUSIONS: No consistent relationships were observed between increased copayments per dispensing and medical care utilization and expense. Future research needs to address the impact on the classes of medications received and related health status, and the impact of larger increases in copayments per dispensing on medical care and health-related factors
Business · Cost sharing · Drug · Health care · Health maintenance · Medical emergency · Medical expenses · Medical prescription · Prescription drug · Utilization management · Healthcare Policy and Management · Medication Adherence and Compliance · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmacology
The seed of abundance and misery
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
Prescription Drug Cost Sharing
Effect of Prescription Drug Coverage on the Elderly's Use of Prescription Drugs
Who Benefits from the Fixed Copayment of Medical and Pharmaceutical Expenditure among the Korean Elderly
M edicare P art D and Its Effect on the Use of Prescription Drugs and Use of Other Health Care Services of the Elderly
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures
The Health Effects of Restricting Prescription Medication Use Because of Cost
Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization
Medication Cost-Sharing
Clinically Sensitive Cost-Sharing for Prescription Drugs
The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada
| Obras citantes distintas | 13 |
|---|---|
| Citas por año | 0,52 |
| Intervalo de citas | 2001 - 2020 (20) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 12 |